# Fibroblasts as key effectors of acupuncture in treatment of rheumatoid arthritis

**Authors:** Shi-Wei Tu, Jun Kawanokuchi, Ken Takagi, Yang-Yang Liu, Jun-Yi Li, Kai-Yuan Deng, Yan-Wei Li, Kai-Fang Yao, Zhi-Han Chen, Ze-Zhi Fan, Zhi-Fang Xu, Yu-Ping Sa, Xiao-Wei Lin, Shen-Jun Wang, Yu-Xin Fang, Xia Liu, Ning Ma, Yi Guo

PMC · DOI: 10.3389/fimmu.2026.1715313 · 2026-01-22

## TL;DR

This study shows that acupuncture helps treat rheumatoid arthritis by activating fibroblasts in fascial tissues, reducing pain and inflammation.

## Contribution

The study identifies fibroblasts as key mediators of acupuncture's therapeutic effects in rheumatoid arthritis.

## Key findings

- Manual acupuncture ameliorated joint-associated fascia pathology in a mouse model of arthritis.
- Fibroblast activation was linked to upregulated ECM and mechanosensitive molecules after acupuncture.
- Fibroblast ablation reduced acupuncture's analgesic effects and collagen fiber deposition.

## Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial inflammation, cartilage degradation, and bone erosion. The diseases also involves pathological changes in the surrounding fascial tissues that lead to persistent pain. Current clinical treatments rely primarily on non-steroidal anti-inflammatory drugs and analgesics, which often have limited efficacy and potential side effects. Manual acupuncture (MA), a traditional therapeutic modality, has shown promising effects in alleviating RA-related symptoms. However, the underlying mechanisms remain largely unclear. Fibroblasts, which are known for their mechanosensitivity and immunomodulatory functions, may play a crucial role in mediating the therapeutic effects of acupuncture. In this study, we demonstrated that MA significantly ameliorated pathological changes in joint-associated fascia in a murine model of adjuvant-induced arthritis with minimal impact on bone and cartilage morphology. Post-acupuncture analysis revealed the upregulation of extracellular matrix (ECM)-related genes and proteins, such as fibromodulin, collagen I, and hyaluronan synthase 2, along with increased expression of mechanosensitive molecules, including Piezo1, Ras homolog family member A (RhoA), and Yes-associated protein 1 (YAP1). Moreover, local changes were observed in the expression of fibroblast-associated markers including Fibroblast Growth Factor 2 (FGF-2), Fibroblast Growth Factor 7 (FGF-7), Fibroblast-Specific Protein 1 (FSP-1), Cannabinoid Receptor 2 (CB2), and Proliferating Cell Nuclear Antigen (PCNA). Notably, selective ablation of fibroblasts in the acupoint area via recombinant adeno-associated virus -mediated apoptosis significantly attenuated the analgesic effect of acupuncture, accompanied by reduced collagen fiber deposition, decreased mast cell degranulation, and downregulation of ECM components and regulatory molecules, such as Hyaluronan Binding Protein 2 (HABP2) and CB2. In conclusion, the study findings suggest that acupuncture alleviates RA-induced pathological and pain responses by activating fibroblasts in the fascial tissue. This mechanotransduction process likely involves the downstream modulation of cannabinoid receptors and ECM-related proteins, including hyaluronic acid and collagen.

## Linked entities

- **Genes:** PIEZO1 (piezo type mechanosensitive ion channel component 1 (Er blood group)) [NCBI Gene 9780], RHOA (ras homolog family member A) [NCBI Gene 387], YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413], FGF2 (fibroblast growth factor 2) [NCBI Gene 2247], FGF7 (fibroblast growth factor 7) [NCBI Gene 2252], S100A4 (S100 calcium binding protein A4) [NCBI Gene 6275], CNR2 (cannabinoid receptor 2) [NCBI Gene 1269], PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111], HABP2 (hyaluronan binding protein 2) [NCBI Gene 3026]
- **Diseases:** rheumatoid arthritis (MONDO:0008383)

## Full-text entities

- **Genes:** PIEZO1 (piezo type mechanosensitive ion channel component 1 (Er blood group)) [NCBI Gene 9780] {aka DHS, ER, FAM38A, LMPH3, LMPHM6, Mib}, PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111] {aka ATLD2}, FMOD (fibromodulin) [NCBI Gene 2331] {aka FM, SLRR2E}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, RHOA (ras homolog family member A) [NCBI Gene 387] {aka ARH12, ARHA, EDFAOB, RHO12, RHOH12}, HABP2 (hyaluronan binding protein 2) [NCBI Gene 3026] {aka FSAP, HABP, HGFAL, NMTC5, PHBP, PHBSP}, HAS2 (hyaluronan synthase 2) [NCBI Gene 3037], FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, S100A4 (S100 calcium binding protein A4) [NCBI Gene 6275] {aka 18A2, 42A, CAPL, FSP1, MTS1, P9KA}, FGF7 (fibroblast growth factor 7) [NCBI Gene 2252] {aka HBGF-7, KGF}, CNR2 (cannabinoid receptor 2) [NCBI Gene 1269] {aka CB-2, CB2, CX5}
- **Diseases:** cartilage degradation (MESH:D002357), RA (MESH:D001172), bone erosion (MESH:D014077), autoimmune disease (MESH:D001327), inflammatory (MESH:D007249), arthritis (MESH:D001168), pain (MESH:D010146)
- **Chemicals:** hyaluronic acid (MESH:D006820)
- **Species:** Adeno-associated virus (species) [taxon 272636], Mus musculus (house mouse, species) [taxon 10090]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12872514/full.md

---
Source: https://tomesphere.com/paper/PMC12872514